MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkin"

  • 2018 International Congress

    Nigral stimulation for the treatment of refractory gait disturbances in Parkinson’s disease

    M. Carmona-Abellán, D. Moreno, M. Alegre, J. Guridi, R. Luquin (Pamplona, Spain)

    Objective: Evaluate the effect of SNr stimulation on freezing of gait and analyse changes in local field potentials. We describe an early-onset Parkinson´s disease patient…
  • 2018 International Congress

    Disrupted Amplitude of Low-frequency Fluctuations and Causal Connectivity in Parkinson’s Disease with Apathy

    Y. Shen, J. Li, Y. Yuan, X. Wang, M. Wang, J. Wang, H. Zhang, L. Zhu, K. Zhang (Nanjing, China)

    Objective: We aimed to explore associated neural substrates changes in Parkinson’s disease (PD) with apathy via amplitude of low-frequency fluctuations (ALFF) and Granger Causality Analysis…
  • 2018 International Congress

    The Impact of short in-patient rehabilitation courses for people with Parkinson´s disease

    S. Kinos, K. Martikainen, T. Vahlberg, R. Marttila (Turku, Finland)

    Objective: To find out whether a 10 to 14 days group-based multidisciplinary in-patient rehabilitation course for patients with Parkinson´s disease has any long-term effect on…
  • 2018 International Congress

    Assessing the Quality of Economic Evaluation of Treatment Options for Parkinson’s disease Using the Quality of Health Economic Studies (QHES) Scale

    M. Azharuddin, M. Adil, P. Ghosh, M. Sharma (New Delhi, India)

    Objective: The objective of this study was to critically appraise all the published evidences on the economic evaluation of treatment options for Parkinson’s disease. Background:…
  • 2018 International Congress

    MRI volumetrics in parkinsonian syndromes

    K. Ma, A. Chan, L. Shi, J. Abrigo, T. Cheung, C. Lau, V. Mok (Hong Kong, Hong Kong)

    Objective: We aimed to explore the ability of MRI volumetrics by using an automated segmentation software called Accubrain in differentiating (1) between different parkinsonian syndromes…
  • 2018 International Congress

    How well can nurses recognize motor fluctuations in Parkinson’s disease: A survey of 238 registered nurses

    K. Boonpang, O. Jitkritsadakul, P. Plengsri, S. Chaiwong, N. Kantachadvanich, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To evaluate awareness of the three main parkinsonian motor symptomatologies, among general nursing population. Background: One aim of Parkinson’s disease (PD) management is to…
  • 2018 International Congress

    Integrated whole exome sequencing and chromosomal microarray in familial Parkinson’s disease

    L. Robak, R. Du, B. Yuan, S. Gu, Z. Akdemir, J. Jankovic, J. Lupski, J. Shulman (Houston, TX, USA)

    Objective: To determine whether whole exome sequencing (WES) plus chromosomal microarray analysis (CMA) yield a genetic etiology in a cohort of 110 individuals with familial…
  • 2018 International Congress

    Increased Parkin expression in a PARK20 (SYNJ1 mutation) iPSCs-based model

    W. Mandemakers, R. Masius, E. Berger, M. Grochowska, M. Quadri, M. Minneboo, M. Picillo, P. Barone, J. Schwamborn, V. Bonifati (Rotterdam, Netherlands)

    Objective: To generate mechanistic insight into how the SYNJ1 p.Arg258Gln mutation leads to neurodegeneration in juvenile Parkinsonism. Background: In humans, the SYNJ1 homozygous p.Arg258Gln missense…
  • 2018 International Congress

    Expanding the canvas of PARKIN mutations and clinical phenotypes in familial and early onset Parkinson’s disease patients

    S. Pandey, L. Tomar, S. Kumar, B. Thelma (New Delhi, India)

    Objective: To identify PARKIN mutations in PD patients with familial history (FPD) and early onset PD patients with no family history (EOPD; ≤50 years) and…
  • 2018 International Congress

    Early-onset Parkinson’s disease in seven patients with heterozygosity for parkin mutation

    C. Lima, A. Novo, M. Sousa, M. Almeida, A. Morgadinho, C. Januário (Coimbra, Portugal)

    Objective: To present and discuss a series of 7 patients with early-onset Parkinson’s Disease and heterozygosity for PARK2 mutation. Background: Parkin mutation in homozygosity or…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley